Arkansas Epilepsy Program — Little Rock, Arkansas

Arkansas Epilepsy Program is a clinical research site located in Little Rock, Arkansas, United States 72205.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Arkansas Epilepsy Program has participated in 5 clinical trials.

Therapeutic areas: Epilepsies, Partial, Partial Onset Seizures, Secondarily Generalized Seizures.

Sponsors: Marinus Pharmaceuticals, Eisai Inc., SK Life Science, Inc..

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Arkansas Epilepsy Program?

Arkansas Epilepsy Program has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Arkansas Epilepsy Program conducted?

Arkansas Epilepsy Program has 5 clinical trials on record. Their work covers Epilepsies, Partial, Partial Onset Seizures, Secondarily Generalized Seizures.

Is Arkansas Epilepsy Program accredited by Crixeo Health?

Yes — Arkansas Epilepsy Program holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Arkansas Epilepsy Program?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.